These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
175 related items for PubMed ID: 3468610
1. [Retrospective study of 30 cases of myelodysplastic syndrome according to the French-American-British classification]. Piguet D, Schmidt PM, Delacrétaz F, Mermillod B. Schweiz Med Wochenschr; 1987 Jan 10; 117(2):61-6. PubMed ID: 3468610 [Abstract] [Full Text] [Related]
4. Myelodysplastic syndromes in childhood. Report of 21 patients from Italy and West Germany. Creutzig U, Cantù-Rajnoldi A, Ritter J, Romitti L, Odenwald E, Conter V, Riehm H, Masera G. Am J Pediatr Hematol Oncol; 1987 Jan 10; 9(4):324-30. PubMed ID: 3439582 [Abstract] [Full Text] [Related]
5. [Chromosome abnormalities in myelodysplastic syndrome]. Fujita K, Mori H, Niikura H, Terada H, Shinohara T. Rinsho Byori; 1990 Aug 10; 38(8):911-6. PubMed ID: 2232253 [Abstract] [Full Text] [Related]
6. Comparison of five prognostic scoring systems, the French-American-British (FAB) and World Health Organization (WHO) classifications in patients with myelodysplastic syndromes: Results of a single-center analysis. Müller-Berndorff H, Haas PS, Kunzmann R, Schulte-Mönting J, Lübbert M. Ann Hematol; 2006 Aug 10; 85(8):502-13. PubMed ID: 16715299 [Abstract] [Full Text] [Related]
9. Classification and scoring systems in myelodysplastic syndromes: a retrospective analysis of 311 patients. Navarro I, Ruiz MA, Cabello A, Collado R, Ferrer R, Hueso J, Martinez J, Miguel A, Orero MT, Pérez P, Nolasco A, Carbonell F. Leuk Res; 2006 Aug 10; 30(8):971-7. PubMed ID: 16423393 [Abstract] [Full Text] [Related]
14. The myelodysplastic syndromes. Part I. What are they? Part II. Classification. Galton DA. Scand J Haematol Suppl; 1986 Aug 10; 45():11-20. PubMed ID: 3515515 [No Abstract] [Full Text] [Related]
15. Circulating myeloid colony-forming cells predict survival in myelodysplastic syndromes. Berer A, Jäger E, Sagaster V, Streubel B, Wimazal F, Sperr WR, Welterman A, Schwarzinger I, Frommlet F, Haas OA, Valent P, Lechner K, Geissler K, Ohler L. Ann Hematol; 2003 May 10; 82(5):271-7. PubMed ID: 12739063 [Abstract] [Full Text] [Related]
17. Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden. Warlick ED, Cioc A, Defor T, Dolan M, Weisdorf D. Biol Blood Marrow Transplant; 2009 Jan 10; 15(1):30-8. PubMed ID: 19135940 [Abstract] [Full Text] [Related]
18. Low dose cytosine arabinoside in the treatment of myelodysplastic syndrome. Nair R, Saikia TK, Gopal R, Nair CN, Soman CS, Advani SH. J Assoc Physicians India; 1996 Mar 10; 44(3):181-3. PubMed ID: 9251314 [Abstract] [Full Text] [Related]
19. Myelodysplastic syndromes in patients under 50 years old: a single institution experience. Breccia M, Mengarelli A, Mancini M, Biondo F, Gentilini F, Latagliata R, Mandelli F, Alimena G. Leuk Res; 2005 Jul 10; 29(7):749-54. PubMed ID: 15927670 [Abstract] [Full Text] [Related]
20. Trisomy 14 in myelodysplastic syndromes: report of two cases and review of the literature. Vasef MA, Murata-Collins JL, Alsabeh R, Medeiros LJ. Arch Pathol Lab Med; 1998 Jan 10; 122(1):77-83. PubMed ID: 9448022 [Abstract] [Full Text] [Related] Page: [Next] [New Search]